John W. Childs logo

John W. Childs

Description

John W. Childs is a Director of Kleo Pharmaceuticals. He serves as the Chairman and Partner of J.W. Childs Associates, L.P., a private equit...

Investor Profile

John W. Childs has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Precision Medicine
  • Health Diagnostics
  • Neuroscience
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does John W. Childs frequently co-invest with?

Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 2
Co-Investments: 2
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 2
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 2
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Venrock
North America, California, United States, Palo Alto
Co-Investments: 2
Aisling Capital
North America, New York, United States, New York
Co-Investments: 2

Which angels does John W. Childs often collaborate with?

CI
North America, New York, United States, New York
Shared Deals: 1
GB
Europe, England, United Kingdom, London
Shared Deals: 2

What are some of recent deals done by John W. Childs?

Bristol-Myers Squibb

New York, New York, United States

Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.

BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Post Ipo EquityFeb 21, 2017
Amount Raised: $80,000,000
Biohaven Pharmaceutical

New Haven, Connecticut, United States

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

BiotechnologyHealth CareHealth DiagnosticsNeurosciencePharmaceutical
Series UnknownNov 1, 2016
Amount Raised: $80,000,000

Find More Investors Like John W. Childs

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

John W. Childs | Pipeseed